Journey Medical (DERM) Total Liabilities (2020 - 2026)

Journey Medical's Total Liabilities history runs 7 years deep, the most recent figure standing at $60.7 million for Q1 2026.

• Quarterly Total Liabilities fell 4.29% year-over-year to $60.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.7 million (down 4.29% YoY) and the FY2025 annual result came in at $62.7 million, up 4.26% from the prior year.
• Total Liabilities was $60.7 million for Q1 2026 at Journey Medical, down from $62.7 million in the prior quarter.
• Across five years, Total Liabilities topped out at $88.4 million in Q1 2023 and bottomed at $48.5 million in Q3 2023.
• A 5-year average of $65.9 million and a median of $61.9 million in 2025 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities soared 59.62% — and 2023, when it slumped 40.77%.
• Journey Medical's Total Liabilities stood at $88.2 million in 2022, then tumbled by 35.93% to $56.5 million in 2023, then advanced by 6.5% to $60.2 million in 2024, then advanced by 4.26% to $62.7 million in 2025, then retreated by 3.24% to $60.7 million in 2026.
• Business Quant data shows DERM's Total Liabilities at $60.7 million in Q1 2026, $62.7 million in Q4 2025, and $59.3 million in Q3 2025.